Receive The Newest Study Notifications

RESEARCH TRIANGLE PARK, N.C., Nov. 01, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company has begun a Phase 1 clinical trial with BCX9250, an oral activin receptor-like kinase-2 (ALK-2) inhibitor discovered and...

Finnish biopharmaceutical company Desentum is about to initiate a first-in-human clinical trial with its birch pollen hypoallergen designed to improve immunotherapeutic treatment of birch pollen allergy. In a funding round arranged by Springvest Oy, the company...

Novartis announced results from its EXCEED clinical trial comparing its Cosentyx (secukinumab) to AbbVie’s bestselling Humira (adalimumab) in patients with active psoriatic arthritis. Cosentyx apparently fell a little bit short in showing statistically significant...

You could get paid $3,310 if you're willing to have yourself deliberately infected with the flu. Researchers want to see how pre-existing antibodies impact a patient's flu symptoms after exposure to the virus. A clinical trial is looking for healthy adults age 18 to...

IND clearance enables commencement of clinical trial to evaluate NEXI-001 in AML/MDS patients with relapsed disease after allogeneic stem cell transplant IND clearance validates Company’s Artificial Immune Modulation (AIM) nanoparticle technology platform Subsequent...

NEW YORK, Oct. 31, 2019 /PRNewswire/ -- In order to promote one's business online, different platforms must be used. While some may be more applicable than others, they can be used to advertise to wider audiences. With this in mind, fishbat shares 3 types of ad...

Geneva, Switzerland and Boston, MA – October 31, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s...

MORRISVILLE, N.C.--(BUSINESS WIRE)-- 15 patients have been randomized 83% initial response rate to qualify for randomization Pulmonary capillary wedge pressure (PCWP) was reduced , on average, by 8 mmHg during exercise following the initial levosimendan infusion No...

Studies Aim to Confirm Safety and Efficacy of Novel Bio-inspired Clot-dissolving Therapy CAMBRIDGE, Mass, USA October 30, 2019 / B3C newswire / -- Thrombolytic Science, LLC (TSI) today announced progress with 10 patients enrolled in its prospective, randomized,...

- Voclosporin ophthalmic solution (VOS) AUDREY trial results anticipated in the second half of 2020 – VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical...

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 31, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe unmet medical needs, today announced the publication of 26-week...

Pinteon Therapeutics today announced the launch of a Phase 1 trial of PNT001, a novel tau antibody that uniquely targets a toxic epitope known to drive neurodegenerative disease. Pinteon is funded by a $17 million Series A from Morningside Ventures and led by an...

Coalition for Epidemic Preparedness Innovations (CEPI) partnership will support Themis’ development and manufacturing of vaccine candidate VIENNA, Austria & OSLO, Norway--(BUSINESS WIRE)-- Themis Bioscience and CEPI – the Coalition for Epidemic Preparedness...

- Data is being presented as a poster today at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference in Boston - STRO-002 was well tolerated in patients with advanced relapsed and refractory ovarian cancer and demonstrated preliminary evidence of...

  Pivotal results expected in March/April 2020 Details of the program to be reviewed at company’s Investor Day today in NY REDWOOD CITY, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company,...

Contract research organizations (CROs) are making significant progress in advancing the industrywide move to improve clinical trial performance, according to the Veeva 2019 Unified Clinical Operations Survey: Annual CRO Report, one of the largest-ever surveys of...

- Data is being presented as a poster today at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference in Boston - STRO-002 was well tolerated in patients with advanced relapsed and refractory ovarian cancer and demonstrated preliminary evidence of...

Since search engines have prioritized websites that are mobile friendly, there have been ongoing efforts by marketing companies to ensure that their clients' websites are viewable on all devices. To maintain said efforts, fishbat discusses the importance of a mobile...

Advances Second Late Stage Program for ADAM Microneedle Technology FREMONT, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has begun enrolling cluster headache...

- Generalized anxiety disorder impacts approximately 7 million U.S. adults annually and many do not fully respond to current therapies - Troriluzole is a new chemical entity that modulates glutamate in an effort to reduce the severity of anxiety, worry and functional...